Cambridge Nutritional Sciences plc Stock
Equities
ODX
GB00B1VCP282
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.9 GBX | 0.00% | -1.27% | +62.50% |
Apr. 22 | Cambridge Nutritional Sciences Nonexecutive Chair Steps Down; Successor Named | MT |
Apr. 22 | Cambridge Nutritional Sciences plc Provides Earnings Guidance for the Year Ended 31 March 2024 | CI |
Sales 2024 * | 9M 11.3M | Sales 2025 * | - | Capitalization | 9.28M 11.65M |
---|---|---|---|---|---|
Net income 2024 * | -1M -1.26M | Net income 2025 * | - | EV / Sales 2024 * | 0.56 x |
Net cash position 2024 * | 4.2M 5.27M | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-7.8
x | P/E ratio 2025 * |
-
| Employees | 91 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 90.83% |
Latest transcript on Cambridge Nutritional Sciences plc
1 week | -1.27% | ||
1 month | +16.42% | ||
3 months | +44.44% | ||
6 months | +44.44% | ||
Current year | +62.50% |
Managers | Title | Age | Since |
---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jag Grewal
CEO | Chief Executive Officer | 54 | 11-06-29 |
Jeremy Millard
BRD | Director/Board Member | 53 | 19-02-28 |
Carolyn Rand
CHM | Chairman | 60 | 23-08-16 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-13 | 3.9 | 0.00% | 372,371 |
24-05-10 | 3.9 | 0.00% | 250,821 |
24-05-09 | 3.9 | 0.00% | 135,263 |
24-05-08 | 3.9 | -1.27% | 247,488 |
Delayed Quote London S.E., May 13, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+62.50% | 11.61M | |
-3.58% | 12.64B | |
-1.48% | 8.46B | |
+8.70% | 5.66B | |
+25.61% | 5.27B | |
-4.58% | 4.49B | |
-51.80% | 3.11B | |
+16.25% | 2.87B | |
+30.25% | 2.31B | |
-4.08% | 1.89B |
- Stock Market
- Equities
- ODX Stock